Navigation Links
Amgen to Appeal CHMP Opinion on Vectibix® (Panitumumab) Use With Chemotherapy in Metastatic Colorectal Cancer in Europe
Date:3/30/2011

itors and there can be no guarantee of our ability to obtain or maintain patent protection for our products or product candidates. We cannot guarantee that we will be able to produce commercially successful products or maintain the commercial success of our existing products. Our stock price may be affected by actual or perceived market opportunity, competitive position, and success or failure of our products or product candidates. Further, the discovery of significant problems with a product similar to one of our products that implicate an entire class of products could have a material adverse effect on sales of the affected products and on our business and results of operations.

The scientific information discussed in this statement related to our product candidates is preliminary and investigative and is not part of the labeling approved by the U.S. FDA or the European Medicines Agency (EMA) for the products. The products are not approved for the investigational use(s) discussed in this news release, and no conclusions can or should be drawn regarding the safety or effectiveness of the products for these uses. Only the FDA, EMA or other applicable regulatory bodies can determine whether the products are safe and effective for these uses. Healthcare professionals should refer to and rely upon the approved labeling for the products, and not the information discussed in this statement.

CONTACT: Amgen
Carrie Deverell: +41 41 3690 308 (E.U. media)
Christine Regan: +1 (805) 447-5476 (U.S. media)
Arvind Sood: +1 (805)-447-1060 (investors)

(i)  Douillard, JE et al. Randomized, Phase 3 Study (PRIME) of Panitumumab with FOLFOX4 versus FOLFOX4 Alone as First-Line Treatment in Patients With Previously Untreated Metastatic Colorectal Cancer. J Clin Oncol 28. 2010.
(ii)  Peeters, M et al. Randomized Phase III Study of Panitumumab With Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) Compared With FOLFIRI Alone As Sec
'/>"/>

SOURCE Amgen
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Amgen Donates $1 Million to Help Japanese Disaster Victims
2. Amgen Completes Acquisition of BioVex
3. NBPTS and Amgen Foundation Join to Bolster Science Education
4. Amgen to Present at the Citi 2011 Global Healthcare Conference
5. CURE Magazine Teams Up With Amgen Oncology and Breakaway from Cancer® to Launch 2011 Extraordinary Healer Award for Oncology Nursing
6. Boehringer Ingelheim to Purchase Amgens Fremont (USA) Facility
7. Amgen’s Fourth Quarter 2010 Adjusted Earnings Per Share Increased 11 Percent to $1.17; Full Year 2010 Adjusted Earnings Per Share Increased 6 Percent to $5.21
8. Genelux Corporation Expands Board of Directors, Appointing Dennis Fenton, Former Amgen Executive
9. Boehringer Ingelheim to Purchase Amgens Fremont (California) Facility
10. MedImmune In-Licenses Clinical-Stage Anti-Inflammatory Monoclonal Antibody From Amgen
11. Amgen to Present at the 29th Annual JP Morgan Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2015)... April 27, 2015  CytoSorbents Corporation (NASDAQ: ... commercializing its CytoSorb® extracorporeal cytokine adsorber to purify ... of Dr. Joerg Scheier , M.D. as ... is a specialist in intensive care medicine and ... experience in treating critically-ill patients and in the ...
(Date:4/27/2015)... BRH Medical, Ltd., today announced ... Notification Application (510k) with the US Food and Drug ... Medical expects feedback from the FDA during the next ... following FDA pre-market clearance. Additional pre-market regulatory filings are ... CEO for BRH Medical, commented, "We are thrilled to ...
(Date:4/27/2015)... 2015 BioLife Solutions , Inc. (NASDAQ: ... of proprietary clinical grade hypothermic storage and ... shipping products for cells and tissues ("BioLife" or ... and Drug Administration has confirmed acceptance of the Company,s ... not an endorsement nor approval of BioLife,s products for ...
Breaking Medicine Technology:CytoSorbents Appoints Dr. Joerg Scheier as European Medical Director 2CytoSorbents Appoints Dr. Joerg Scheier as European Medical Director 3CytoSorbents Appoints Dr. Joerg Scheier as European Medical Director 4CytoSorbents Appoints Dr. Joerg Scheier as European Medical Director 5BRH Medical, Ltd., Announces Filing of a Pre-Market Submission with the US Food and Drug Administration (FDA) for the BRH-A2 Tissue Management System 2BioLife Solutions Submits FDA Master Files for Cell Thawing Media Products 2BioLife Solutions Submits FDA Master Files for Cell Thawing Media Products 3BioLife Solutions Submits FDA Master Files for Cell Thawing Media Products 4
... - 12-week study concludes that new cosmeceutical improves skin ... Calif., May 4 Senetek PLC (OTC ... the development of technologies that target the science of ... "Topical PRK-124 (0.125%) Lotion for Improving the Signs and ...
... Experience Significant Improvement in Ocular Surface Disease and Quality ... Inc. announced today that results from a large (n ... ophthalmic insert will be presented this week during the ... Vision and Ophthalmology (ARVO), May 3-7, Ft. Lauderdale, FL, ...
Cached Medicine Technology:Spotlight on Rosacea Advance - May Issue of Journal of Drugs in Dermatology Features Pyratine XR(TM) Clinical Study 2ARVO, AOS: Large Study of Lacrisert(R) Dry Eye Insert; 2ARVO, AOS: Large Study of Lacrisert(R) Dry Eye Insert; 3ARVO, AOS: Large Study of Lacrisert(R) Dry Eye Insert; 4ARVO, AOS: Large Study of Lacrisert(R) Dry Eye Insert; 5
(Date:4/27/2015)... April 27, 2015 The Doctors on ... connect clients of personal injury attorneys with the best doctors ... has seen steady growth throughout their history and that trend ... DC and his team in the Tujunga / ... doctor and massage therapist, patients can find comprehensive care and ...
(Date:4/27/2015)... (PRWEB) April 27, 2015 Data Integrity ... Within Your Operations or Your Partners/Suppliers, **FDAnews Webinar**, May ... http://www.fdanews.com/DataIntegrity , Data integrity issues have become ... few years., Uncovering data integrity issues within manufacturing operations ... integrity issues come to light, remediating them can be ...
(Date:4/27/2015)... Como, Italy (PRWEB) April 27, 2015 ... that the design project SMRT IMAGE Lumica by Boombang ... of the Platinum A' Design Award in Scientific Instruments, ... Category. , Insights on SMRT IMAGE Lumica, Boombang Inc ... Product work SMRT IMAGE Lumica explained “SMRT Image Lumica ...
(Date:4/27/2015)... Telematics Berlin is Europe’s biggest Automotive ... CE players and the government to discuss the opportunities ... car. This year’s panel on connected car security with ... Commission, is an opportunity to hear and contribute towards ... Automotive Security Standard for years to come. , ...
(Date:4/27/2015)... Attorney Dan Newlin, of the Law ... his clients, took that commitment to a whole new level ... makes it easier for existing and potential clients to contact ... brand and added value to the firm’s services, #Dan covers ... Newlin has law offices. , “I knew the pound sign ...
Breaking Medicine News(10 mins):Health News:Prominent Doctors with Distinguished Backgrounds Join Doctors on Liens in Tujunga 2Health News:FDAnews Announces — Data Integrity Problems on the Rise: Confronting Data Integrity Issues Within Your Operations or Your Partners/Suppliers Webinar, May 19, 2015 2Health News:FDAnews Announces — Data Integrity Problems on the Rise: Confronting Data Integrity Issues Within Your Operations or Your Partners/Suppliers Webinar, May 19, 2015 3Health News:FDAnews Announces — Data Integrity Problems on the Rise: Confronting Data Integrity Issues Within Your Operations or Your Partners/Suppliers Webinar, May 19, 2015 4Health News:Boombang Inc Design Team wins Platinum in A' Medical Product Design Awards 2Health News:Telematics Berlin: European Commission discuss a pan European Automotive Security Strategy 2Health News:Telematics Berlin: European Commission discuss a pan European Automotive Security Strategy 3Health News:Dan Newlin Hashtags It With #Dan 2
... healthy crackle in the air! We have just been chipped in ... – chips! Wipe away that guilt// and let yourself have a ... complete range of McCain’s frozen chips has received the ‘green-signal’ from ... fat and saturated fat. The agency has accorded this brand of ...
... hundred villages in India will soon be well equipped ... centers - with the active involvement// of Indian American ... we would promote better hygiene, clean drinking water and ... also be given to creating awareness about vector borne ...
... with gonorrhea is probably twice as likely to develop bladder ... results in the British Journal of Cancer, lead author David ... the statement based on case studies of around 51,000 American ... men suffering from gonorrhea. Results analyzed showed that ...
... specially grown soy beans may prove to be successful ... says Tulane //University cancer researcher Matthew Burow. ... with ovarian and breast cancer tumors that are stimulated ... further growth of the tumors by interfering with the ...
... "gold-standard" amongst researchers for scientific studies. On the one ... has also questioned the worth of allopathic medicine practices, ... medicine (CAM) practices. Majority of CAM practices are difficult, ... ,The question arises as to whether EBM principles are ...
... blood thinning drugs quintupled during the 1990s, according to a ... than tenfold. ,Most of the increase is due ... prescribed to prevent blood clotting. Blood clots can lead to ... brain hemorrhage is a stroke caused by bleeding in the ...
Cached Medicine News:Health News:Better Healthcare for 100 Villages - Courtesy Indian American Physicians 2Health News:Is Evidence-based Medicine Enough to Support Additional Research in Alternative Medicine? 2
Angled for temporal approach. Open 14 mm rounded blades for patient comfort. Dull finish....
Open wire style blades allow complete manipulation of the phaco tip inside the eye. Lid control is excellent, exposure is maximized, and the likelihood of positive pressure is reduced....
Pediatric model. Blades: 10 mm. Solid blades with locking mechanism. Dull finish....
Fenestrated 16 mm blades. Self-locking mechanism. Dull finish....
Medicine Products: